Published in J Am Coll Cardiol on April 23, 2007
Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patients. Am J Kidney Dis (2014) 2.06
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev (2015) 1.94
Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev (2014) 1.38
Surgical management of cardiac implantable electronic device infections. J Thorac Dis (2014) 1.20
Biological pacemaker created by minimally invasive somatic reprogramming in pigs with complete heart block. Sci Transl Med (2014) 1.12
Analysis of bacterial biofilms using NMR-based metabolomics. Future Med Chem (2012) 1.11
Pacemaker lead endocarditis due to multidrug-resistant Corynebacterium striatum detected with sonication of the device. J Clin Microbiol (2010) 1.11
Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis (2013) 1.10
Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections. J Interv Card Electrophysiol (2011) 1.05
Unusual treatment of pacemaker pocket infection: a case report. J Tehran Heart Cent (2010) 1.04
Subcutaneous chronic implantable defibrillation systems in humans. J Interv Card Electrophysiol (2012) 0.98
Cardiac device-related endocarditis caused by Paenibacillus glucanolyticus. J Clin Microbiol (2013) 0.97
Infective endocarditis--prophylaxis, diagnostic criteria, and treatment. Dtsch Arztebl Int (2009) 0.97
Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. Future Microbiol (2011) 0.92
Infection after ICD implantation: operating room versus cardiac catheterisation laboratory. Neth Heart J (2009) 0.90
Trends in incidence of infective endocarditis at the Medical Center of Alkmaar. Neth Heart J (2015) 0.88
Sonication of explanted cardiac implants improves microbial detection in cardiac device infections. J Clin Microbiol (2012) 0.88
Cardiac Implantable Electronic Device Infection in Patients at Risk. Arrhythm Electrophysiol Rev (2016) 0.86
Incidence of cardiac implantable electronic device infections and migrations in Japan: Results from a 129 institute survey. J Arrhythm (2015) 0.84
Evolution of nasal carriage of methicillin-resistant coagulase-negative staphylococci in a remote population. Antimicrob Agents Chemother (2011) 0.84
New horizon for infection prevention technology and implantable device. J Arrhythm (2016) 0.84
Role of ¹⁸F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective study. Eur J Nucl Med Mol Imaging (2014) 0.83
Management of Cardiac Electronic Device Infections: Challenges and Outcomes. Arrhythm Electrophysiol Rev (2016) 0.80
Device extraction in adults with congenital heart disease. Pacing Clin Electrophysiol (2009) 0.80
Early diagnosis of cardiac implantable electronic device generator pocket infection using ¹⁸F-FDG-PET/CT. Eur Heart J Cardiovasc Imaging (2015) 0.79
Septic Pulmonary Embolism Caused by Infected Pacemaker Leads After Replacement of a Cardiac Resynchronization Therapy Device. Am J Case Rep (2016) 0.79
The prevalence of methicillin resistant organisms among pacemaker and defibrillator implant recipients. Am J Cardiovasc Dis (2012) 0.78
Two cases of cardiac device-related endocarditis due to Streptococcus dysgalactiae subsp. equisimilis (group C or G streptococci). BMC Infect Dis (2014) 0.78
Cardiac device infection due to Streptococcus pneumoniae. Can J Infect Dis Med Microbiol (2012) 0.78
Long-term outcome of complete cardiovascular implantable electronic device removal with cardiopulmonary bypass. J Artif Organs (2013) 0.78
Clinical use of antibacterial mesh envelopes in cardiovascular electronic device implantations. Med Devices (Auckl) (2015) 0.77
Genetic identification and risk factor analysis of asymptomatic bacterial colonization on cardiovascular implantable electronic devices. Biomed Res Int (2014) 0.77
Cardiovascular implantable electronic device infections in left ventricular assist device recipients. Pacing Clin Electrophysiol (2013) 0.76
Pacemaker endocarditis: an important clinical entity. BMJ Case Rep (2009) 0.76
Combination prophylactic therapy with rifampin increases efficacy against an experimental Staphylococcus epidermidis subcutaneous implant-related infection. Antimicrob Agents Chemother (2014) 0.76
Identification of bacteriology and risk factor analysis of asymptomatic bacterial colonization in pacemaker replacement patients. PLoS One (2015) 0.75
Right-sided infective endocarditis as a potentially fatal complication in patients with long-term refractory severe bradyarrhythmia after cervical spinal cord injury: A case report. J Arrhythm (2014) 0.75
Radiology of cardiac devices and their complications. Br J Radiol (2014) 0.75
Cardiovascular Implantable Electronic Device Infections due to Propionibacterium Species. Pacing Clin Electrophysiol (2016) 0.75
Management of Cardiovascular Implantable Electronic Devices Infections in High-Risk Patients. Arrhythm Electrophysiol Rev (2015) 0.75
Biomarker-based diagnosis of pacemaker and implantable cardioverter defibrillator pocket infections: A prospective, multicentre, case-control evaluation. PLoS One (2017) 0.75
Successful surgical management of pace-marker induced infective endocarditis under the guidance of real-time three-dimensional trans-esophageal echocardiogram. J Cardiothorac Surg (2014) 0.75
Cardiac implantable electronic device infection due to Mycobacterium species: a case report and review of the literature. BMC Res Notes (2016) 0.75
Management of a remnant electrode in a patient with cardioverter-defibrillator infection after refusal of intravascular electrode removal. Korean Circ J (2011) 0.75
Management of Cardiac Implantable Electronic Device Infection. Arrhythm Electrophysiol Rev (2014) 0.75
Lead extractions in patients with cardiac implantable electronic device infections: Single center experience. J Arrhythm (2016) 0.75
Perioperative management for the prevention of bacterial infection in cardiac implantable electronic device placement. J Arrhythm (2015) 0.75
A cardiac implantable device infection by Raoultella planticola in an immunocompromized patient. JMM Case Rep (2017) 0.75
Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol (2014) 0.75
Microbiological Characteristics and Clinical Features of Cardiac Implantable Electronic Device Infections at a Tertiary Hospital in China. Front Microbiol (2017) 0.75
Serratia marcescens: A Rare Cause of Recurrent Implantable Cardioverter Defibrillator Site Infection. Case Rep Cardiol (2015) 0.75
eComment. Surgical complications of permanent cardiac pacemaker insertion. Interact Cardiovasc Thorac Surg (2012) 0.75
Treatment of Infected Cardiac Implantable Electronic Devices. Semin Plast Surg (2016) 0.75
Infections of cardiac implantable electronic devices. Indian Pacing Electrophysiol J (2014) 0.75
Microbial colonization of electrocardiographic telemetry systems before and after cleaning. Am J Crit Care (2013) 0.75
Considerations for cardiac device lead extraction. Nat Rev Cardiol (2016) 0.75
Remnant Pacemaker Lead Tips after Lead Extractions in Pacemaker Infections. Korean Circ J (2016) 0.75
Thrombolysis is an appropriate treatment in lead-associated infective endocarditis with giant vegetations located on the right atrial lead. BMJ Case Rep (2012) 0.75
A misplaced window. BMJ Case Rep (2012) 0.75
Clinical analysis of the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation. Exp Ther Med (2017) 0.75
[Local antibiotic therapy]. Unfallchirurg (2017) 0.75
Delayed Pacemaker Generator Pocket and Lead Primary Infection Due to Burkholderia Cepacia. Am J Case Rep (2017) 0.75
[Upgrading to biventricular pacing: indications and procedural challenges]. Herzschrittmacherther Elektrophysiol (2008) 0.75
[Device related infections. How to identify and how to treat]. Herzschrittmacherther Elektrophysiol (2013) 0.75
In vivo biocompatibility and pacing function study of silver ion-based antimicrobial surface technology applied to cardiac pacemakers. Open Heart (2017) 0.75
[Predictors for need of antibradycardia and antitachycardia pacing after ICD implantation : Implications for the subcutaneous ICD]. Herzschrittmacherther Elektrophysiol (2016) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Cardiac resynchronization in chronic heart failure. N Engl J Med (2002) 17.52
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2012) 8.56
Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med (2007) 7.82
Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation (2012) 5.25
Incidence and predictors of cardiac perforation after permanent pacemaker placement. Heart Rhythm (2005) 4.39
Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker. N Engl J Med (2015) 4.26
An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis (2003) 3.93
Association of atrial fibrillation and obstructive sleep apnea. Circulation (2004) 3.81
Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med (2004) 3.75
Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation (2007) 3.57
Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation (2010) 3.17
Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol (2013) 3.03
Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation (2003) 2.99
Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines. Circulation (2012) 2.97
Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation (2010) 2.93
Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA (2005) 2.92
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation (2015) 2.84
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm (2008) 2.75
Electrophysiologic characteristics of ventricular arrhythmias arising from the aortic mitral continuity-potential role of the conduction system. J Cardiovasc Electrophysiol (2015) 2.73
Microbiologic diagnosis of prosthetic shoulder infection by use of implant sonication. J Clin Microbiol (2009) 2.69
High leukocyte count is associated with peripheral vascular dysfunction in individuals with low cardiovascular risk. Circ J (2012) 2.61
Stroke or transient ischemic attack in patients with transvenous pacemaker or defibrillator and echocardiographically detected patent foramen ovale. Circulation (2013) 2.56
Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis (2010) 2.54
Fungal endocarditis, 1995-2000. Chest (2002) 2.52
A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis (2011) 2.50
Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation (2010) 2.45
The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis. Clin Infect Dis (2006) 2.37
HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm (2010) 2.35
Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2013) 2.22
Nonvalvular cardiovascular device-related infections. Circulation (2003) 2.19
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Cardiovasc Electrophysiol (2002) 2.14
Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med (2007) 2.14
Culture-negative prosthetic joint infection. Clin Infect Dis (2007) 2.13
Impact of implanted recalled sprint Fidelis lead on patient mortality. J Am Coll Cardiol (2011) 2.08
Cardiac resynchronization therapy: Part 1--issues before device implantation. J Am Coll Cardiol (2005) 2.06
Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol (2002) 2.04
Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med (2007) 2.03
Use of cellular telephones in the hospital environment. Mayo Clin Proc (2007) 2.01
Clinical competency statement: Training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. Heart Rhythm (2004) 2.01
Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation. Heart Rhythm (2013) 1.99
Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions. J Am Coll Cardiol (2005) 1.98
Sonication of explanted prosthetic components in bags for diagnosis of prosthetic joint infection is associated with risk of contamination. J Clin Microbiol (2006) 1.93
Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm (2009) 1.84
Molecular and antibiofilm approaches to prosthetic joint infection. Clin Orthop Relat Res (2003) 1.82
Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol. J Cardiovasc Electrophysiol (2003) 1.81
Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. Heart Rhythm (2011) 1.80
HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm (2008) 1.79
Quality and strength of evidence of the Infectious Diseases Society of America clinical practice guidelines. Clin Infect Dis (2010) 1.79
Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin Infect Dis (2011) 1.78
Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol (2005) 1.78
Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore) (2007) 1.75
Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators. Heart Rhythm (2006) 1.74
Cardiac resynchronization therapy for heart failure. Circulation (2003) 1.74
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm (2008) 1.72
Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: the ALTITUDE REDUCES study. J Cardiovasc Electrophysiol (2011) 1.69
The natural history of lone atrial flutter. Ann Intern Med (2004) 1.68
Avian influenza: a new pandemic threat? Mayo Clin Proc (2004) 1.67
Upgrade and de novo cardiac resynchronization therapy: impact of paced or intrinsic QRS morphology on outcomes and survival. Heart Rhythm (2009) 1.67
Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis (2006) 1.66